Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

McCormick Place

Jun 18, 2017 8:30 AM - Jun 22, 2017 12:45 PM

2301 South Martin Luther King Jr. Drive, Gate 4, Chicago, IL 60616

DIA 2017 Annual Meeting

The Future of Patient Engagement: Measuring What Matters

Session Chair(s)

Debra  Lappin, JD

Debra Lappin, JD

Head, Health Biosciences Practice , FaegreBD Consulting, United States

As awareness and theory around patient engagement in the medical product life cycle have matured, stakeholders are now focusing on best practices and implementation of patient centric strategies. In this session, patient, industry, and regulatory stakeholders will share their perspectives on today’s meaning of effective engagement and what the future state of patient engagement will look like. Panelists will discuss what they believe should be the outcomes of their investments of effort and how we can engage patients to identify the outcomes that matter most. The idea of “return on engagement” will be explored: how do we measure what matters? How do we turn insights into regulatory utilities? And how do we capture the return – to drug and device development – on this investment in patient engagement?

Join Patient Engagement Community for a follow up Round Table discussion at 12:30pm in the Community Corner.

Learning Objective : Describe the meaning of effective patient engagement and where it should take place during the medical product life cycle; Discuss approaches to involving patients in the determination of meaningful outcomes throughout the life cycle of medical therapies; Identify potential measures that could demonstrate the return on meaningful engagement for patient, regulatory, and industry stakeholders. Explore patient engagement in today’s policy environment and in the context of global harmonization.

Speaker(s)

Anne C. Beal, MD, MPH

Panelist

Senior VP, Chief Patient Officer and Global Head of Patient Centricity, Sanofi, France

Juan  Garcia-Burgos, MD, PHD

Panelist

Head of Public and Stakeholders Engagement Department, European Medicines Agency, Netherlands

K. Kimberly  McCleary

Panelist

Founder and Chief Executive Officer, The Kith Collective, LLC, United States

Paul  Kluetz, MD

Panelist

Deputy Director, Oncology Center of Excellence, OC, FDA, United States

Ronald Joseph Bartek, MA

Panelist

Co-Founder/Founding President, Friedreich's Ataxia Research Alliance (FARA), United States

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.